Anna Zamojska-Jaroszewicz

Anna Zamojska-Jaroszewicz is a seasoned professional in the biopharmaceutical and biotechnology sectors, currently serving as the Drug Substance Manufacturing Director and Head of the CTO Office at Polpharma Biologics since October 2018. Anna has significant expertise in drug substance manufacturing, project management, and technology transfer, with a track record in research and development for biologically active substances at various organizations, including BIOTON S.A. and Medical University of Gdansk. With an academic background that includes a Ph.D. in Chemical and Process Engineering from Warsaw University of Technology and multiple roles in academia, Anna has contributed to advancements in bioprocess engineering, technology optimization, and the development of renewable energy sources, earning recognition for innovative research and methodologies in these fields.